Novartis Eyes Gene Therapy Growth With Vedere Acquisition

Paying $150m Upfront

 
• By Kevin Grogan
  
Eye in an high tech environment
Novartis expanding eye gene therapy presence • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies